| 171 |
Chronic cytotoxicity of the serous membrane leading to pleural/peritoneal mesotheliomas in the rat. |
Charles Wood |
BY-SA |
None
|
1090: Increased, mesotheliomas
|
|
|
| 170 |
Anti-dopaminergic activity leading to mammary adenomas and carcinomas in the SD rat |
Charles Wood |
BY-SA |
None
|
1079: Increased, Adenomas/carcinomas (mammary)
|
|
|
| 169 |
GnRH pulse disruption leading to pituitary adenomas and carcinomas in the SD rat. |
Charles Wood |
BY-SA |
None
|
1082: Increased, adenomas (pituitary)
|
|
|
| 168 |
GnRH pulse disruption leading to mammary adenomas and carcinomas in the SD rat. |
Charles Wood |
BY-SA |
None
|
1079: Increased, Adenomas/carcinomas (mammary)
|
|
|
| 167 |
Early-life estrogen receptor agonism leading to endometrial adenosquamous carcinoma via promotion of sine oculis homeobox 1 progenitor cells |
Travis Karschnik |
BY-SA |
111: Agonism, Estrogen receptor
|
1070: Increased, adenosquamous carcinomas of endometrium
|
|
|
| 166 |
PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse |
Charles Wood |
BY-SA |
None
|
1063: Increased, Pancreatic acinar tumors
|
|
|
| 165 |
Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse |
Charles Wood |
BY-SA |
None
|
2 AOs
|
|
|
| 164 |
Beta-2 adrenergic agonist activity leading to mesovarian leiomyomas in the rat and mouse |
Charles Wood |
BY-SA |
1038: Activation, beta-2 adrenergic receptor
|
1044: Promotion, mesovarian leiomyomas
|
|
|
| 163 |
PPARgamma activation leading to sarcomas in rats, mice, and hamsters |
Charles Wood |
BY-SA |
1028: Activation of specific nuclear receptors, PPAR-gamma activation
|
None
|
|
|
| 162 |
Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas in the rat and mouse |
Charles Wood |
BY-SA |
None
|
741: Increase, Adenomas/carcinomas (follicular cell)
|
|
|
| 161 |
Glutamate-gated chloride channel activation leading to neurotransmission inhibition associated mortality |
Knut Erik Tollefsen |
BY-SA |
1018: Activation, Glutamate-gated chloride channels
|
351: Increased Mortality
|
|
|
| 160 |
Ionotropic gamma-aminobutyric acid receptor activation mediated neurotransmission inhibition leading to mortality |
Knut Erik Tollefsen |
BY-SA |
762: Activation, ionotropic GABA Receptor chloride channel
|
351: Increased Mortality
|
|
|
| 159 |
Thyroperoxidase inhibition leading to increased mortality via reduced anterior swim bladder inflation |
Dries Knapen |
BY-SA |
279: Thyroperoxidase, Inhibition
|
2 AOs
|
WPHA/WNT Endorsed |
1.35 |
| 158 |
Deiodinase 1 inhibition leading to increased mortality via reduced anterior swim bladder inflation |
Dries Knapen |
BY-SA |
1009: Inhibition, Deiodinase 1
|
2 AOs
|
WPHA/WNT Endorsed |
1.35 |
| 157 |
Deiodinase 1 inhibition leading to increased mortality via reduced posterior swim bladder inflation |
Dries Knapen |
BY-SA |
1009: Inhibition, Deiodinase 1
|
2 AOs
|
WPHA/WNT Endorsed |
1.35 |
| 156 |
Deiodinase 2 inhibition leading to increased mortality via reduced anterior swim bladder inflation |
Dries Knapen |
BY-SA |
1002: Inhibition, Deiodinase 2
|
2 AOs
|
WPHA/WNT Endorsed |
1.35 |
| 155 |
Deiodinase 2 inhibition leading to increased mortality via reduced posterior swim bladder inflation |
Dries Knapen |
BY-SA |
1002: Inhibition, Deiodinase 2
|
2 AOs
|
WPHA/WNT Endorsed |
1.35 |
| 154 |
Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response |
Takumi Ohishi |
BY-SA |
980: Inhibition, Calcineurin Activity
|
984: Impairment, T-cell dependent antibody response
|
WPHA/WNT Endorsed |
1.38 |
| 153 |
Aromatase Inhibition leading to Ovulation Inhibition and Decreased Fertility in Female Rats |
Undefined |
BY-SA |
964: Inhibition of Aromatase Enzyme, Chemical exposure during critical window of estrous cycle between diestrus 2 and proestrus inhibits aromatase conversion of testosterone to estradiol
|
972: Decreased fertility, Reduced number of oocytes ovulated
|
|
|
| 152 |
Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity |
Kristie Sullivan |
BY-SA |
957: Binding, Transthyretin in serum
|
402: Cognitive function, decreased
|
Under Development |
1.41 |
| 151 |
AhR activation leading to preeclampsia |
Sabrina Tait |
BY-SA |
18: Activation, AhR
|
1893: increase, Preeclampsia
|
Under Development |
1.42 |
| 150 |
Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF |
Amani Farhat |
BY-SA |
18: Activation, AhR
|
947: Increase, Early Life Stage Mortality
|
WPHA/WNT Endorsed |
1.7 |
| 149 |
Peptide Oxidation Leading to Hypertension |
Frazer Lowe |
BY-SA |
209: Peptide Oxidation
|
952: Hypertension
|
Under Development |
1.50 |
| 148 |
EGFR Activation Leading to Decreased Lung Function |
Karsta Luettich |
BY-SA |
941: Activation, EGFR
|
1250: Decrease, Lung function
|
Under Development |
1.51 |
| 146 |
Estrogen Receptor Activation and Female Precocious Puberty |
Undefined |
Open for adoption |
None
|
None
|
|
|